Inventor
PUSHKO PETER M
US18 patents
⚠️ This page may combine multiple inventors who share the name “PUSHKO PETER M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVAVAX INC
15 patentsUS7763450B2Jul 27, 2010
Functional influenza virus-like particles (VLPs)
NOVAVAX INC48 citations96
US9050290B2Jun 9, 2015
Functional influenza virus like particles (VLPs)
NOVAVAX INC18 citations92
US11052146B2Jul 6, 2021
Modified RSV F proteins and methods of their use
NOVAVAX INC3 citations84
US9731000B2Aug 15, 2017
Modified RSV F proteins and methods of their use
NOVAVAX INC7 citations84
US9717786B2Aug 1, 2017
Modified RSV F proteins and methods of their use
NOVAVAX INC7 citations84
US9694066B2Jul 4, 2017
Functional influenza virus like particles (VLPs)
NOVAVAX INC6 citations83
US9474799B2Oct 25, 2016
Functional influenza virus-like particles (VLPS)
NOVAVAX INC8 citations83
US12357684B2Jul 15, 2025
Modified RSV F proteins and methods of their use
NOVAVAX INC2 citations74
US11446374B2Sep 20, 2022
Modified RSV F proteins and methods of their use
NOVAVAX INC5 citations73
US10188723B2Jan 29, 2019
Functional influenza virus like particles (VLPs)
NOVAVAX INC2 citations72
US9956280B2May 1, 2018
Functional influenza virus-like particles (VLPs)
NOVAVAX INC3 citations72
US9951317B2Apr 24, 2018
Highly efficient influenza matrix (M1) proteins
NOVAVAX INC1 citations60
US10729760B2Aug 4, 2020
Functional influenza virus like particles (VLPs)
NOVAVAX INC0 citations51
US10548968B2Feb 4, 2020
Functional influenza virus-like particles (VLPS)
NOVAVAX INC0 citations51
US10544399B2Jan 28, 2020
Highly efficient influenza matrix (M1) proteins
NOVAVAX INC0 citations49